Martingale Asset Management’s Spero Therapeutics SPRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-43,908	Closed	-$491K	–	1033
2020 Q3	$491K	Sell	43,908 -33,500	-43%	-$375K	0.01%	820
2020 Q2	$1.05M	Buy	+77,408	New	+$1.05M	0.01%	718